Neurocrine Biosciences, Inc.
Key Metrics
Market Snapshot
About
Neurocrine Biosciences, Inc. discovers and develops treatments for neurological, neuroendocrine, and neuropsychiatric disorders. The company markets INGREZZA for tardive dyskinesia and develops a pipeline targeting conditions like schizophrenia, endometriosis, and congenital adrenal hyperplasia. Neurocrine focuses on diseases with significant unmet medical needs where neurological pathways play a central role.